Bertoli S, Bérard E, Peterlin P, Guieze R, Desbrosses Y, Hicheri Y, Benbrahim O, Carre M, Orvain C, Banos A, Bernard M, Gyan E, Saad A, Chebrek S, Guepin GR, Dorvaux V, Sanhes L, Gallego-Hernanz MP, Exbrayat C, Vincent L, Himberlin C, Simand C, Vey N, Fenoll C, Mineur A, Huynh A, Vergez F, Luquet I, Largeaud L, Delabesse E, Pigneux A, Récher C, Leukemia Organization FILO FI. Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02). haematol [Internet]. 2020Sep.10 [cited 2025Feb.22];. Available from: https://haematologica.org/article/view/11935